 |
 |

Seoul-Type Keratoprosthesis
Preliminary Results of the First 7 Human Cases
Mee Kum Kim, MD;
Jae Lim Lee, MD;
Won Ryang Wee, MD;
Jin Hak Lee, MD
Arch Ophthalmol. 2002;120:761-766.
Objective To evaluate the clinical efficacy of a newly designed Seoul-type keratoprosthesis
(S-KPro).
Methods The S-KPro, which consists of a polymethyl methacrylate optic, a skirt
(polyurethane or polypropylene), and polypropylene haptics, was developed
and implanted into 2 unsighted and 5 sighted eyes of 7 patients. One patient
had a chemical burn, another had an ocular pemphigoid, and the remainder were
diagnosed as having Stevens-Johnson syndrome. The preoperative visual acuities
ranged from light perception to hand motions. The average follow-up time was
25.6 months.
Main Outcome Measures We evaluated anatomical stability, visual acuity, retinal status, and
the visual field.
Results At the last follow-up visit, the S-KPro was well placed in 6 patients.
The best-corrected visual acuities of the sighted patients ranged from 20/100
to 20/60 in the affected eye. One patient each experienced retinal detachment
or endophthalmitis. Partial extrusion was found in the patient with glaucoma.
A retroprosthetic membrane was detected in 1 patient and was treated with
an Nd:YAG laser. No glaucomatous visual field defects were found in any of
the sighted patients.
Conclusions Anatomical success was achieved in 6 of 7 eyes. In 3 of the 5 sighted
eyes, the S-KPro could rehabilitate corneal blindness not correctable with
keratoplasty.
From the Departments of Ophthalmology, Seoul Municipal Boramae Hospital,
Seoul (Dr Kim), Chungnam National University Hospital, Taejon (Dr J. L. Lee),
and Seoul National University College of Medicine and Seoul Artificial Eye
Center, Seoul National University Hospital Clinical Research Center, Seoul
(Drs Wee and J. H. Lee), Korea.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Biological Response to a SupraDescemetic Synthetic Cornea in Rabbits
Stoiber et al.
Arch Ophthalmol 2004;122:1850-1855.
ABSTRACT
| FULL TEXT
Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure
Alio et al.
Br. J. Ophthalmol. 2004;88:1585-1589.
ABSTRACT
| FULL TEXT
|